Nationwide voluntary recall of all products for sterile use from compounding pharmacy located in Cedar Park, Texas
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Nationwide voluntary recall of all products for sterile use from compounding pharmacy located in Cedar Park, Texas

Filetype[PDF-1.15 MB]


English
Details You May Also Like

Details:

  • Corporate Authors:
  • Description:
    August 14, 2013, 16:00:00 ET (4:00:00 PM ET

    CDCHAN-00353

    Summary: The U.S. Food and Drug Administration (FDA) is alerting health care providers and patients of a voluntary nationwide recall of all products produced and distributed for sterile use by Specialty Compounding, LLC, Cedar Park, Texas. There have been recent reports of bacterial bloodstream infections potentially related to the company's calcium gluconate infusions.

    CDC and the FDA are working with Texas state officials to determine the scope of the contamination. According to the FDA, information provided by the firm stated that the recalled products (i.e., all products produced and distributed for sterile use by Specialty Compounding) were distributed directly to patients nationwide, with the exception of North Carolina, which received no products. The full text of the recall is available on the FDA website at http://www.fda.gov/Safety/Recalls/ucm364643.htm?source=govdelivery. Also according to the FDA, information provided by the firm stated that recalled products were also distributed to hospitals and physician offices in Texas.

    CDC and the FDA are working with Texas state officials to determine the scope of the contamination.

    According to the FDA, information provided by the firm stated that the recalled products (i.e., all products produced and distributed for sterile use by Specialty Compounding) were distributed directly to patients nationwide, with the exception of North Carolina, which received no products. The full text of the recall is available on the FDA website at http://www.fda.gov/Safety/Recalls/ucm364643.htm?source=govdelivery. Also according to the FDA, information provided by the firm stated that recalled products were also distributed to hospitals and physician offices in Texas.

  • Subjects:
  • Series:
    HAN ; 353
  • Document Type:
    HAN Health Advisory
  • Place as Subject:
    Texas
  • Pages in Document:
    2 unnumbered pages
  • Volume:
    353
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov